Please assess the completion status of the following clinical trial:

Trial Title: Periurethral Pro-ACTTM Balloons vs Retrourethral AdvanceXP(TM) Male Sling for Post-prostatectomy Incontinence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* Patient presenting mild to moderate stress urinary incontinence (20g \< 72 hours pad-test \< 300g) following radical prostatectomy more than 1 year ago.~* Patient capable of roaming, independent and capable of using toilet without any trouble.~* Patients able to answer to questionnaire and communicate in French~* Informed consent~* Patients with social security~Exclusion Criteria:~* Uncontrolled prostatic adenocarcinoma or PSA \> 1 ng/ml~* Maximum urinary flow rate \< 15 ml/sec~* Postvoid residual volume \> 150 ml~* Urinated volume in 24h \> 3000 ml~* Uninhibited detrusor contractions associated with leakage during the preoperative urodynamic assessment (realized under anticholinergic if the patient is usually under this medication)~* Severe incontinence (Pad test \> 300g/24h)~* History of artificial urinary sphincter~* Known neurologic bladder dysfunction~* History of neurological disease which can interfere with the urinary symptoms~* Presence of a urethral stenosis or of an anastomotic stricture during the preoperative endoscopy.~* Previous treatment with pelvic radiation therapy in 6 months before inclusion~* Uncontrolled urinary tract infection~* Patients affected by an infiltrative bladder tumour~* Patients with bladder stones~* Severe constitutional hemorrhagic disease or haemophilia~* Deep depression of immune system~* Severe renal impairment or obstructive pathology of the upper urinary tract with severe renal impairment

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental (Type: EXPERIMENTAL): Patients will receive AdvanceXP retrourethral male sling implantation under general or loco-regional anaesthesia, by perineal approach. The sling is placed via transobturator route
- Active comparator (Type: ACTIVE_COMPARATOR): Patients will receive Pro-ACT balloons implantation under general or loco-regional anaesthesia, by perineal approach. The balloons are placed under X-ray control laterally to the urethra, under the bladder neck. The extremity of the device (titanium port), linked to the balloon, is located subcutaneously in the scrotum. During post-operative visits, readjustments of the volume of the balloons will be made under local anaesthesia. The volume will be increased or decreased according to the patients symptoms.

Based on this trial design, predict the completion outcome and termination type (if applicable).